Compare · CHE vs HIMS
CHE vs HIMS
Side-by-side comparison of Chemed Corp (CHE) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.96B, about 1.1x HIMS ($6.46B).
- CHE has been more active in the news (11 items in the past 4 weeks vs 6 for HIMS).
- HIMS has more recent analyst coverage (25 ratings vs 8 for CHE).
- Company
- Chemed Corp
- Hims & Hers Health Inc.
- Price
- $542.58+1.64%
- $25.23-8.85%
- Market cap
- $6.96B
- $6.46B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 11
- 6
- Recent ratings
- 8
- 25
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest CHE
- Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference
- SEC Form 10-Q filed by Chemed Corp
- Chemed upgraded by Jefferies with a new price target
- SEC Form 8-K filed by Chemed Corp
- Chemed Reports Third-Quarter 2026 Results
- SEC Form 4 filed by Chemed Corp
- SEC Form 4 filed by Chemed Corp
- SEC Form 4 filed by Chemed Corp
- SEC Form 4 filed by Chemed Corp
- SEC Form 4 filed by Chemed Corp
Latest HIMS
- Chief Legal Officer Boughton Soleil sold $95,551 worth of shares (3,462 units at $27.60) as part of a pre-agreed trading plan (SEC Form 4)
- Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
- Chief Legal Officer Boughton Soleil sold $100,577 worth of shares (3,461 units at $29.06) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)